Skip to content

DMAAU DRUGS MADE IN AMER ACQUTN CO

Follow

UNIT 10/15/2029 (unit), issuer CIK 2028614

5 managers (5 13F filers) reported a position in DMAAU shares at 2025-12-31, 563,050 shares in all. 0 filers opened a position and 3 filers sold out during the quarter.

Managers
5
13F filers
5
New
0
Added
2
Reduced
1
Sold out
3
Shares held by filers
563,050

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2025

Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
KRYGER CAPITAL Ltd303,810$3.04M0.24%+3,81013F-HRTimeline
WOLVERINE ASSET MANAGEMENT LLCin group WOLVERINE ASSET MANAGEMENT LLC130,000$1.37M0.02%013F-HRTimelineGroup
Clear Street Group Inc.in group Clear Street Group Inc.91,219$957K0.01%+43,73613F-HRTimelineGroup
ROBINSON CAPITAL MANAGEMENT, LLC30,000$315K0.13%013F-HRTimeline
UBS Group AGin group UBS Group AG8,021$84.3K<0.01%-10,36413F-HRTimelineGroup